# Aclaris Therapeutics, Inc.: filings

ACRS · Nasdaq · CIK 1557746 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acrs.md) · [Financials](/companies/acrs/financials.md) · [Filings](/companies/acrs/filings.md) · [Insiders](/companies/acrs/insiders.md)

## Reports and events: 230 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 377, 8-K 153, SC 13G/A 58, 3 35, 10-Q 33, SC 13G 31, 424B5 15, S-8 13, SCHEDULE 13G/A 12, 10-K 11, DEF 14A 11, SC 13D/A 10, 424B3 9, CORRESP 9, DEFA14A 8, CT ORDER 7, D 7, EFFECT 7, UPLOAD 7, SCHEDULE 13G 6, ARS 4, S-3 4, 144 3, S-1/A 3, SC 13D 3, 424B4 2, 4/A 2, 8-K/A 2, PRE 14A 2, S-1 2, S-3ASR 2, S-3MEF 2, 10-K/A 1, 10-Q/A 1, 8-A12B 1, CERTNAS 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, POS AM 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 17:25 ET | [8-K](/filings/0001104659-26-119231.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-119231 |
| 2026-10-27 | 06:06 ET | [8-K](/filings/0001104659-26-118952.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-118952 |
| 2026-08-06 | 17:15 ET | [8-K](/filings/0001104659-26-092128.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-092128 |
| 2026-08-06 | 16:31 ET | [10-Q](/filings/0001104659-26-092065.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092065 |
| 2026-08-06 | 07:15 ET | [8-K](/filings/0001104659-26-091629.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091629 |
| 2026-06-04 | 16:01 ET | [8-K](/filings/0001104659-26-070494.md) | 5.07 Shareholder vote results | 0001104659-26-070494 |
| 2026-05-07 | 16:32 ET | [10-Q](/filings/0001104659-26-057202.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057202 |
| 2026-05-07 | 07:15 ET | [8-K](/filings/0001104659-26-056669.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056669 |
| 2026-04-28 | 06:45 ET | [8-K](/filings/0001104659-26-049733.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-049733 |
| 2026-04-23 | 07:45 ET | [DEF 14A](/filings/0001104659-26-047262.md) | Proxy statement, period 2026-06-04 | 0001104659-26-047262 |
| 2026-03-11 | 16:30 ET | [8-K](/filings/0001104659-26-026407.md) | 7.01 Regulation FD disclosure | 0001104659-26-026407 |
| 2026-03-10 | 21:51 ET | [8-K](/filings/0001104659-26-025420.md) | 7.01 Regulation FD disclosure | 0001104659-26-025420 |
| 2026-02-26 | 16:31 ET | [10-K](/filings/0001104659-26-020540.md) | Annual report, period 2025-12-31 | 0001104659-26-020540 |
| 2026-02-26 | 07:15 ET | [8-K](/filings/0001104659-26-020070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020070 |
| 2026-01-12 | 07:00 ET | [8-K](/filings/0001104659-26-002694.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002694 |
| 2026-01-06 | 07:15 ET | [8-K](/filings/0001104659-26-001076.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-001076 |
| 2025-11-06 | 16:31 ET | [10-Q](/filings/0001104659-25-107788.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107788 |
| 2025-11-06 | 07:01 ET | [8-K](/filings/0001104659-25-107353.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107353 |
| 2025-10-14 | 06:59 ET | [8-K](/filings/0001104659-25-098991.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-098991 |
| 2025-08-07 | 16:31 ET | [10-Q](/filings/0001558370-25-010789.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010789 |
| 2025-08-07 | 07:15 ET | [8-K](/filings/0001558370-25-010640.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010640 |
| 2025-07-29 | 16:15 ET | [8-K](/filings/0001558370-25-009739.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-009739 |
| 2025-06-30 | 06:59 ET | [8-K](/filings/0001558370-25-008984.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008984 |
| 2025-06-05 | 16:01 ET | [8-K](/filings/0001558370-25-008430.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008430 |
| 2025-05-08 | 16:30 ET | [10-Q](/filings/0001558370-25-006993.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006993 |
| 2025-05-08 | 07:15 ET | [8-K](/filings/0001558370-25-006851.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006851 |
| 2025-04-24 | 07:00 ET | [DEF 14A](/filings/0001558370-25-005332.md) | Proxy statement, period 2025-06-05 | 0001558370-25-005332 |
| 2025-02-27 | 16:30 ET | [10-K](/filings/0001558370-25-001819.md) | Annual report, period 2024-12-31 | 0001558370-25-001819 |
| 2025-02-27 | 07:17 ET | [8-K](/filings/0001558370-25-001679.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-001679 |
| 2025-01-13 | 07:00 ET | [8-K](/filings/0001558370-25-000148.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000148 |
| 2024-11-18 | 08:15 ET | [8-K](/filings/0001558370-24-015838.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-015838 |
| 2024-11-06 | 16:30 ET | [10-Q](/filings/0001558370-24-014646.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014646 |
| 2024-11-06 | 07:21 ET | [8-K](/filings/0001558370-24-014522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014522 |
| 2024-08-07 | 16:30 ET | [10-Q](/filings/0001558370-24-011376.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011376 |
| 2024-08-07 | 07:15 ET | [8-K](/filings/0001558370-24-011201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011201 |
| 2024-07-16 | 16:30 ET | [8-K](/filings/0001558370-24-009853.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-009853 |
| 2024-06-07 | 16:15 ET | [8-K](/filings/0001558370-24-009009.md) | 5.07 Shareholder vote results | 0001558370-24-009009 |
| 2024-05-07 | 16:30 ET | [10-Q](/filings/0001558370-24-007069.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007069 |
| 2024-05-07 | 16:15 ET | [8-K](/filings/0001558370-24-007055.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-007055 |
| 2024-04-25 | 07:00 ET | [DEF 14A](/filings/0001558370-24-005677.md) | Proxy statement, period 2024-06-06 | 0001558370-24-005677 |
| 2024-03-19 | 16:30 ET | [8-K](/filings/0001558370-24-003572.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-003572 |
| 2024-02-27 | 07:30 ET | [10-K](/filings/0001558370-24-001753.md) | Annual report, period 2023-12-31 | 0001558370-24-001753 |
| 2024-02-27 | 07:14 ET | [8-K](/filings/0001558370-24-001752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-001752 |
| 2024-02-05 | 16:31 ET | [8-K/A](/filings/0001558370-24-000770.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-000770 |
| 2024-02-05 | 16:30 ET | [8-K](/filings/0001558370-24-000769.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-000769 |
| 2024-01-19 | 07:30 ET | [8-K](/filings/0001558370-24-000373.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-000373 |
| 2023-12-19 | 16:15 ET | [8-K](/filings/0001558370-23-019911.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019911 |
| 2023-11-13 | 07:42 ET | [8-K](/filings/0001558370-23-018691.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-018691 |
| 2023-11-06 | 07:30 ET | [10-Q](/filings/0001558370-23-017660.md) | Quarterly report, period 2023-09-30 | 0001558370-23-017660 |
| 2023-11-06 | 07:15 ET | [8-K](/filings/0001558370-23-017655.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017655 |

Page 1 of 5. [Older](/companies/acrs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.